AstraZeneca (AZNL)

12,859.00p
   
  • Change Today:
      63.00p
  • 52 Week High: 12,938.00p
  • 52 Week Low: 9,642.00p
  • Currency: UK Pounds
  • Shares Issued: 1,264.16m
  • Volume: 390,835
  • Market Cap: £162,559m

Latest ShareCast News

Germany's Cheplapharm pays AstraZeneca $200m for Atacand rights

By Frank Prenesti

Date: Monday 01 Oct 2018

(Sharecast News) - AstraZeneca said it had agreed a $200m deal with Germany's Cheplapharm Arzneimittel for the European commercial rights to Atacand and Atacand Plus heart and hypertension treatments.

AstraZeneca Regulatory News

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 12,859.00p
Change Today 63.00p
% Change 0.49 %
52 Week High 12,938.00p
52 Week Low 9,642.00p
Volume 390,835
Shares Issued 1,264.16m
Market Cap £162,559m

What The Brokers Say

Strong Buy 10
Buy 13
Neutral 3
Sell 0
Strong Sell 1
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 07-Nov-2025

Time Volume / Share Price
16:29 8 @ 12,859.00p
16:29 8 @ 12,859.00p
16:29 8 @ 12,859.00p
16:29 8 @ 12,858.00p
16:29 26 @ 12,858.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page